Parkin-catalyzed Ubiquitin-Ester Transfer Is Triggered by PINK1-dependent Phosphorylation*

  1. Noriyuki Matsuda3
  1. From the Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo 156-8506,
  2. the §Department of Neurology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo 162-8666,
  3. the Department of Neurology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582,
  4. the Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba 277-8561, and
  5. the **Division of Disease Proteomics, Institute for Enzyme Research, The University of Tokushima, Tokushima 770-8503, Japan
  1. 2 To whom correspondence may be addressed. E-mail: tanaka-kj{at}igakuken.or.jp.
  2. 3 Supported by Tomizawa Jun-ichi and Keiko Fund of Molecular Biology Society of Japan for Young Scientist. To whom correspondence may be addressed: Tel.: 81-3-5316-3123; Fax: 81-3-5316-3152; E-mail: matsuda-nr{at}igakuken.or.jp.
  1. 1 These authors contributed equally to this work.

Background: Parkin is a ubiquitin ligase activated by a decrease in the mitochondrial membrane potential (ΔΨm). However, details regarding its mechanism remain limited.

Results: PINK1-dependent phosphorylation of Parkin at Ser-65 following dissipation of ΔΨm triggers ubiquitin-ester transfer by the RING2 domain of Parkin to Cys-431.

Conclusion: Parkin catalyzes trans- (ubiquitin-thioester)ification upon PINK1-dependent phosphorylation.

Significance: The molecular process of Parkin-catalyzed ubiquitylation has been determined.

Abstract

PINK1 and PARKIN are causal genes for autosomal recessive familial Parkinsonism. PINK1 is a mitochondrial Ser/Thr kinase, whereas Parkin functions as an E3 ubiquitin ligase. Under steady-state conditions, Parkin localizes to the cytoplasm where its E3 activity is repressed. A decrease in mitochondrial membrane potential triggers Parkin E3 activity and recruits it to depolarized mitochondria for ubiquitylation of mitochondrial substrates. The molecular basis for how the E3 activity of Parkin is re-established by mitochondrial damage has yet to be determined. Here we provide in vitro biochemical evidence for ubiquitin-thioester formation on Cys-431 of recombinant Parkin. We also report that Parkin forms a ubiquitin-ester following a decrease in mitochondrial membrane potential in cells, and that this event is essential for substrate ubiquitylation. Importantly, the Parkin RING2 domain acts as a transthiolation or acyl-transferring domain rather than an E2-recruiting domain. Furthermore, formation of the ubiquitin-ester depends on PINK1 phosphorylation of Parkin Ser-65. A phosphorylation-deficient mutation completely inhibited formation of the Parkin ubiquitin-ester intermediate, whereas phosphorylation mimics, such as Ser to Glu substitution, enabled partial formation of the intermediate irrespective of Ser-65 phosphorylation. We propose that PINK1-dependent phosphorylation of Parkin leads to the ubiquitin-ester transfer reaction of the RING2 domain, and that this is an essential step in Parkin activation.

Footnotes

  • * This work was supported in part by Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grants 23-6061 (to K. O.), 23791001 (to Y. K.), 21000012 (to K. T.), and 23687018, 24111557, and 25112522 (to N. M.); the Tomizawa Jun-ichi and Keiko Fund for Young Scientist (to N. M.); and the Takeda Science Foundation (to H. K., N. M., and K. T.).

  • Received March 7, 2013.
  • Revision received June 3, 2013.
Table of Contents

This Article

  1. The Journal of Biological Chemistry 288, 22019-22032.
  1. All Versions of this Article:
    1. M113.467530v1
    2. 288/30/22019 (most recent)

Article Usage Stats

Submit your work to JBC.

You'll be in good company.